MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3631-3634

  Li, Hong Yan ^a   Zhang, Yan ^a   Cai, Jian Hui ^a,b   Bian, Hong Lei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

Human colorectal carcinoma cells; MiRNA 451; PI3K AKT pathway; SW620

Indexed keywords

EID: 84882675975     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3631     Document Type: Article

References (28)

1. Akao Y, Nakagawa Y, Naoe T (2007). MicroRNA-143 and -145 in colon cancer. DNA Cell Biol, 26, 311-20.
2. Bandres E, Bitarte N, Arias F, et al (2009). microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res, 15, 2281-90.
3. Bandres E, Cubedo E, Agirre X, et al (2006). Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer, 5, 29.
4. Chen CZ, Li L, Lodish HF, Bartel DP (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science, 303, 83-6.
5. Chen JY, Lin JR, Cimprich KA, Meyer T (2012). A twodimensional ERK-AKT signaling code for an NGF-triggered cell-fate decision. Mol Cell, 45, 196-209.
6. Chen X, Guo X, Zhang H, et al (2009). Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene, 28, 1385-92.
7. Dong H, Tang J, Li LH, et al (2013). Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases. Asian Pac J Cancer Prev, 14, 909-13.
8. Eustace K (2005). Colorectal cancer. Lancet, 365, 166.
9. Gallia GL, Rand V, Siu IM, et al (2006). PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res, 4, 709-14.
10. Gao W, Shen H, Liu L, et al (2011). MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol, 137, 557-66.
11. Godlewski J, Nowicki MO, Bronisz A, et al (2010). MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell, 37, 620-32.
12. Huang Q, Liu L, Liu CH, et al (2013). MicroRNA-21 Regulates the Invasion and Metastasis in Cholangiocarcinoma and May Be a Potential Biomarker for Cancer Prognosis. Asian Pac J Cancer Prev, 14, 829-34.
13. Hui AB, Shi W, Boutros PC, et al (2009). Robust global micro- RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest, 89, 597-606.
14. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
15. Johnson R, Zuccato C, Belyaev ND, et al (2008). A microRNAbased gene dysregulation pathway in Huntington's disease. Neurobiol Dis, 29, 438-45.
16. Katada T, Ishiguro H, Kuwabara Y, et al (2009). microRNA expression profile in undifferentiated gastric cancer. Int J Oncol, 34, 537-42.
17. Kita D, Yonekawa Y, Weller M, Ohgaki H (2007). PIK3CA alterations in primary (de novo) and secondary glioblastomas. Acta Neuropathol, 113, 295-302.
18. Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54.
19. Li X, Sanda T, Look AT, et al (2011). Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J Exp Med, 208, 663-75.
20. Opel D, Westhoff MA, Bender A, et al (2008). Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res, 68, 6271-80.
21. Patrick DM, Zhang CC, Tao Y, et al (2010). Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3- 3zeta. Genes Dev, 24, 1614-9.
22. Prevo R, Deutsch E, Sampson O, et al (2008). Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. Cancer Res, 68, 5915-23.
23. Ren H, Li J, Liu JJ, et al (2012). Anti-HER-2 anti-CD3 bispecific antibodies inhibit growth of HCT-116 colorectal carcinoma cells in vitro and in vivo. Asian Pac J Cancer Prev, 13, 2795-8.
24. Song G, Ouyang G, Bao S (2005). The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med, 9, 59-71.
25. Tian Y, Nan Y, H an L, et al (2012). MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol, 40, 1105-12.
26. Tong AW, Nemunaitis J (2008). Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy. Cancer Gene Ther, 15,341-55.
27. Wang T, Zang WQ, Li M, et al (2013). Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706. Dig Dis Sci, 58, 706-14.
28. Yang ZZ, Tschopp O, Baudry A, et al (2004). Physiological functions of protein kinase B/Akt. Biochem Soc Trans, 32, 350-4.